In alignment with these findings, human CD7+CD1a− L-ICs (hL-ICs) from T-ALL patients likewise exhibit the TAL/LMO gene expression program, cell cycle restriction and chemoresistance, implying a shared phenotype between mouse and human L-ICs. Here, CD7 is linked to acute lymphoblastic leukemia.